Cellebrite DI Ltd.
CLBT
$11.43
-$0.02-0.18%
NASDAQ
| 06/30/2026 | 12/31/2025 | 06/30/2025 | 03/31/2025 | ||
|---|---|---|---|---|---|
| Net Income | 6.37M | 21.26M | 19.48M | 17.40M | |
| Total Depreciation and Amortization | 8.92M | 3.94M | 2.59M | 2.63M | |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | |
| Total Other Non-Cash Items | 13.26M | 14.31M | 3.92M | 5.49M | |
| Change in Net Operating Assets | -10.96M | 47.30M | 6.60M | -4.64M | |
| Cash from Operations | 17.59M | 86.81M | 32.58M | 20.88M | |
| Capital Expenditure | -3.07M | -3.96M | -3.61M | -2.34M | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | 0.00 | -147.46M | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -10.68M | -94.70M | 44.19M | -124.17M | |
| Cash from Investing | -13.75M | -246.11M | 40.58M | -126.50M | |
| Total Debt Issued | -- | -- | -- | -- | |
| Total Debt Repaid | -- | -- | -- | -- | |
| Issuance of Common Stock | 3.61M | 2.34M | 13.83M | 3.62M | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | |
| Cash from Financing | 3.61M | 2.34M | 13.83M | 3.62M | |
| Foreign Exchange rate Adjustments | 110.00K | 56.00K | 1.76M | 822.00K | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | 7.56M | -156.90M | 88.75M | -101.18M | |